Navigation Links
Missed opportunities: Most heart attack patients are not taking preventive medications

Despite a high frequency of cardiac risk factors, patients without known coronary artery disease (CAD) presenting with acute heart attacks, or ST-elevated myocardial infarction (STEMI), are rarely on primary prevention medications, according to study findings to be presented Nov. 15 at the 2010 annual American Heart Association (AHA) Scientific Sessions in Chicago.

The decreasing incidence of STEMI due to acute coronary thrombosis is at least partially related to increased use of primary and secondary prevention, in particular anti-platelet and lipid-lowering therapies, according to the study authors. Still, nearly 400,000 present annually with STEMI in the United States.

"We hypothesized that the use of evidence-based preventive therapy in patients presenting with STEMI would be sub-optimal," says study investigator Kevin J. Graham, MD, president of the Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis.

As part of the Minneapolis Heart Institute Level 1 MI program, which uses a standardized protocol for percutaneous coronary invention (PCI) in STEMI patients in 32 rural and community hospitals, preadmission medications in patients admitted with STEMI are recorded using each patient's electronic medical record.

The researchers assessed the percentage of patients treated with aspirin, statins, and ACE-inhibitors in patients with and without previously diagnosed CAD. From May 1, 2007 to March 1, 2010, they enrolled 1,174 patients with documented STEMI358 with known CAD and 816 without known CAD.

"For those patients with known CAD, 100 percent should be taking aspirin and 90 percent on a statin, but we found only 70 percent were taking aspirin and only 61 percent were taking a statin," explains Graham. "Equally disconcerting is the 815 patients without known coronary disease, half of whom had hypertension and slightly less than half had known hyperlipidemia, and only 22 percent were taking aspirin and 16 percent were taking a statin."

The study authors suggest that the potential reasons for this gap include absence of indications for primary prevention by current guidelines, no previous medical care, inadequate risk factor identification and modification or non-compliance. They add that the use of secondary prevention medication in patients with known CAD was "significantly lower than expected."

"Efforts aimed at detecting early cardiovascular disease and better compliance with appropriate preventive cardiovascular medications may, if successful, produce even further reductions in cardiovascular morbidity and mortality," the researchers conclude.

"Prevention works. These findings speak strongly to the benefits of initiating and maintaining appropriate medication regimens in at-risk patients to prevent vascular events," concludes Graham.


Contact: Meghan Bethke
Minneapolis Heart Institute Foundation

Related medicine news :

1. Outcomes of patients dismissed from the hospital with non-cardiac chest pain
2. Many Kids With Hepatitis C Are Missed
3. 1 in 5 Parents Missed Work for H1N1 School Closings: Survey
4. ICU Patients at Risk for Rare Heart Rhythm Problem
5. Cook With Love This Valentines Day With Heart-Smart Recipes
6. Study finds racial gaps continue in heart disease awareness
7. Highmark Foundation Awards $120,000 to the American Heart Association
8. Womens Heart Disease Awareness Still Lacking
9. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
10. Migraine Linked to Increased Heart Attack Risk
11. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
Post Your Comments:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology: